AQX.L

Aquis Exchange
Aquis Exchange PLC - Director/PDMR Shareholding
19th September 2024, 06:00
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 7779E
Aquis Exchange PLC
19 September 2024
 

19 September 2024

Aquis Exchange PLC

("Aquis", the "Company" or the "Group")

 

Director/PDMR Notification

and

Issue of Options

 

Aquis Exchange PLC (AQX.L), announces that on 18 April 2024, following the 2024 Annual General Meeting, it issued 586,973 options ("Options") over the Company's ordinary shares of 10p each ("Ordinary Shares") to the executive directors of the Company under the Company's Executive Share Option Plan.

 

The nil cost Options granted to the executive directors under the Executive Share Option Plan are exercisable at 480.0p per Ordinary Share (a 25% premium to the average 30-day share price of 384.24p at the time of issuance). 334,450 options were issued to Alasdair Haynes, Chief Executive Officer of the Company, 252,523 to Richard Fisher, Chief Financial Officer of the Company.

 

These options will vest on the third anniversary of the date of issue and expire seven years from the date of issue. Shares issued to the executive directors on exercise of the options will be subject to a further two-year holding period.  Vesting of the options are also subject to recovery and withholding provisions assessed by the Nomination and Remuneration Committee as detailed in the Company's 2023 Annual Report.

 

Enquiries:

 

Aquis Exchange PLC

Tel: +44 (0)20 3597 6321

Alasdair Haynes, CEO


Richard Fisher, CFO

Adele Gilbert, Head of Marketing & Investor Relations

 

Tel: +44 (0)20 3597 6329

 


Investec Bank plc (Nominated Adviser and Broker)

Tel: +44 (0)20 7597 5970

David Anderson


Lydia Zychowska

St John Hunter

 

Canaccord Genuity Limited (Joint Broker)

Emma Gabriel

George Grainger

 

 

 

 

 

Tel: +44 (0) 20 7523 8000

VSA Capital Limited (AQSE Corporate Adviser)

Tel: +44(0)20 3005 5000

Andrew Raca




MHP Group (Financial PR Adviser)

Tel: +44 (0)20 3128 8000

MHP Group

Aquis@mhpgroup.com

Eleni Menikou

 

Robert Collett-Creedy

 

 

Notes to editors:

 

About Aquis Exchange PLC

Aquis Exchange PLC ("Aquis") is Europe's challenger exchange, creating better markets for a modern economy. Aquis has market-leading technology and innovative rules for trading, and offer primary listings and secondary trading of equities, along with global licensing of proprietary technology.

Aquis consists of four divisions:

Aquis Markets operates lit and dark order books, covering 16 European markets. For its lit books, Aquis uses a subscription pricing model which works by charging users according to the message traffic they generate, rather than a percentage of the value of each stock that they trade.

Aquis Technologies is the software and technology division of Aquis. It focuses on building better markets via the creation and licensing of cutting-edge, cost-effective exchange infrastructure technology and services, including matching engine and trade surveillance solutions.

Aquis Stock Exchange (AQSE) is a stock market providing primary and secondary markets for equity and debt products. It is authorised as a Recognised Investment Exchange, which allows it to operate a regulated listings venue. The AQSE Growth Market is divided into two segments 'Access' and 'Apex'; the Access market focuses on earlier stage growth companies, while Apex is the intended market for larger, more established businesses.

Aquis Data generates revenue from the sale of data derived from Aquis Markets and Aquis Stock Exchange to non-Member market participants.

Aquis is authorised and regulated by the UK Financial Conduct Authority and France's Autorité de contrôle prudentiel et de résolution and L'Autorité des marchés financiers to operate Multilateral Trading Facility businesses in the UK & Switzerland markets and in EU27 markets respectively. Aquis Exchange PLC is quoted on the Aquis Stock Exchange and on the AIM Market (AIM) of the LSE. For more information, please go to www.aquis.eu.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them:

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

1.     Alasdair Haynes

2.     Richard Fisher

2

Reason for the notification

 

a)

Position/status

 

1.     Chief Executive Officer

2.     Chief Financial Officer

b)

Initial notification/ Amendment

 

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

Aquis Exchange plc

b)

LEI

 

213800IXJSF5E1SIW150

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

Identification code

 

 

Ordinary shares of 10p each

 

ISIN: GB00BD5JNK30

b)

Nature of the transaction

 

Grant of share options under the Company's Executive Share Option Plan

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

 

Exercise price of 480.0p

 

1.     334,450

2.     252,523

 

 

d)

Aggregated information

Aggregated volume

Price

 

  

 

n/a

e)

Date of the transaction

 

18/04/2024

f)

Place of the transaction 

Outside a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFFFVIAFITLIS]]>
TwitterFacebookLinkedIn